{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:50:00Z","timestamp":1789951800936,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T00:00:00Z","timestamp":1434585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T00:00:00Z","timestamp":1434585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/leu.2015.144","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T02:41:00Z","timestamp":1434595260000},"page":"508-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent manner"],"prefix":"10.1038","volume":"30","author":[{"given":"S","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Borkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kempinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S N","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Danet-Desnoyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A G","family":"Muntean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Cierpicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Grembecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,18]]},"reference":[{"key":"BFleu2015144_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2141.2010.08459.x","volume":"152","author":"R Marschalek","year":"2011","unstructured":"Marschalek R . Mechanisms of leukemogenesis by MLL fusion proteins. Br J Haematol 2011; 152: 141\u2013154.","journal-title":"Br J Haematol"},{"key":"BFleu2015144_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1309\/RX27R8GJQM330C22","volume":"122","author":"MC Cox","year":"2004","unstructured":"Cox MC, Panetta P, Lo-Coco F, Del Poeta G, Venditti A, Maurillo L et al. Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients. Am J Clin Pathol 2004; 122: 298\u2013306.","journal-title":"Am J Clin Pathol"},{"key":"BFleu2015144_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12185-012-1180-0","volume":"96","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Chen A, Yan XM, Huang G . Disordered epigenetic regulation in MLL-related leukemia. Int J Hematol 2012; 96: 428\u2013437.","journal-title":"Int J Hematol"},{"key":"BFleu2015144_CR4","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3324\/haematol.2008.002436","volume":"94","author":"RK Slany","year":"2009","unstructured":"Slany RK . The molecular biology of mixed lineage leukemia. Haematologica 2009; 94: 984\u2013993.","journal-title":"Haematologica"},{"key":"BFleu2015144_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1535-6108(03)00188-0","volume":"4","author":"CW So","year":"2003","unstructured":"So CW, Lin M, Ayton PM, Chen EH, Cleary ML . Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell 2003; 4: 99\u2013110.","journal-title":"Cancer Cell"},{"key":"BFleu2015144_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","volume":"123","author":"A Yokoyama","year":"2005","unstructured":"Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, Cleary ML . The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 2005; 123: 207\u2013218.","journal-title":"Cell"},{"key":"BFleu2015144_CR7","doi-asserted-by":"publisher","first-page":"40690","DOI":"10.1074\/jbc.M110.172783","volume":"285","author":"J Grembecka","year":"2010","unstructured":"Grembecka J, Belcher AM, Hartley T, Cierpicki T . Molecular basis of the mixed lineage leukemia-menin interaction: implications for targeting mixed lineage leukemias. J Biol Chem 2010; 285: 40690\u201340698.","journal-title":"J Biol Chem"},{"key":"BFleu2015144_CR8","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1182\/blood-2012-05-429274","volume":"120","author":"A Shi","year":"2012","unstructured":"Shi A, Murai MJ, He S, Lund G, Hartley T, Purohit T et al. Structural insights into inhibition of the bivalent menin\u2013MLL interaction by small molecules in leukemia. Blood 2012; 120: 4461\u20134469.","journal-title":"Blood"},{"key":"BFleu2015144_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1182\/blood-2013-09-525741","volume":"124","author":"E Manara","year":"2014","unstructured":"Manara E, Baron E, Tregnago C, Aveic S, Bisio V, Bresolin S et al. MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia. Blood 2014; 124: 263\u2013272.","journal-title":"Blood"},{"key":"BFleu2015144_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ng765","volume":"30","author":"SA Armstrong","year":"2002","unstructured":"Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41\u201347.","journal-title":"Nat Genet"},{"key":"BFleu2015144_CR11","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1182\/blood-2010-12-324699","volume":"117","author":"QF Wang","year":"2011","unstructured":"Wang QF, Wu G, Mi S, He F, Wu J, Dong J et al. MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome. Blood 2011; 117: 6895\u20136905.","journal-title":"Blood"},{"key":"BFleu2015144_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","volume":"20","author":"KM Bernt","year":"2011","unstructured":"Bernt KM, Zhu N, Sinha AU, Vempati S, Faber J, Krivtsov AV et al. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 2011; 20: 66\u201378.","journal-title":"Cancer Cell"},{"key":"BFleu2015144_CR13","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/sj.leu.2404401","volume":"20","author":"H Gal","year":"2006","unstructured":"Gal H, Amariglio N, Trakhtenbrot L, Jacob-Hirsh J, Margalit O, Avigdor A et al. Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia 2006; 20: 2147\u20132154.","journal-title":"Leukemia"},{"key":"BFleu2015144_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccell.2015.02.016","volume":"27","author":"D Borkin","year":"2015","unstructured":"Borkin D, He S, Miao H, Kempinska K, Pollock J, Chase J et al. Pharmacologic inhibition of the Menin\u2013MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell 2015; 27: 589\u2013602.","journal-title":"Cancer Cell"},{"key":"BFleu2015144_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nchembio.773","volume":"8","author":"J Grembecka","year":"2012","unstructured":"Grembecka J, He S, Shi A, Purohit T, Muntean AG, Sorenson RJ et al. Menin\u2013MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. Nat Chem Biol 2012; 8: 277\u2013284.","journal-title":"Nat Chem Biol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2015144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015144","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:09:26Z","timestamp":1648728566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2015144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,18]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFleu2015144"],"URL":"https:\/\/doi.org\/10.1038\/leu.2015.144","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,18]]},"assertion":[{"value":"18 June 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Drs Grembecka and Cierpicki received research support from Kura Oncology. They are also receiving compensation as members of the scientific advisory board of Kura Oncology, and they have an equity ownership in the company. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}